UDAY SHANKAR
- Type
- Physician · Allopathic & Osteopathic Physicians / Internal Medicine / Gastroenterology
- Where
- HAZARD, KY
- NPI
- 1881660538
- Received
- $64,480 in 365 records, 2019 to 2025
- As principal investigator
- $44,342 of research payments to others in 35 records
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 128 | $40,425 |
| 2024 | General payment | 106 | $20,745 |
| 2023 | General payment | 47 | $1,067 |
| 2022 | General payment | 34 | $924 |
| 2021 | General payment | 22 | $428 |
| 2020 | General payment | 9 | $157 |
| 2019 | General payment | 19 | $732 |
By company
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 15 | $48,320 |
| Food and Beverage | 321 | $9,235 |
| Travel and Lodging | 23 | $4,344 |
| Consulting Fee | 2 | $2,413 |
| Education | 4 | $165 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-30 | Takeda Pharmaceuticals U.S.A., Inc. | $37 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-12-30 | Takeda Pharmaceuticals U.S.A., Inc. | $31 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-12-18 | Takeda Pharmaceuticals U.S.A., Inc. | $9,545 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-12-18 | Ardelyx, Inc. | $19 | Food and Beverage | In-kind items and services | IBSRELA Drug, GASTROENTEROLOGY | 2025 | |
| 2025-12-15 | Madrigal Pharmaceuticals | $967 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-12-15 | Madrigal Pharmaceuticals | $22 | Food and Beverage | In-kind items and services | REZDIFFRA Drug, LIVER DISEASE | 2025 | |
| 2025-12-11 | Janssen Biotech, Inc. | $118 | Food and Beverage | In-kind items and services | TREMFYA Drug, Immunology | 2025 | |
| 2025-12-09 | Takeda Pharmaceuticals U.S.A., Inc. | $576 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-12-04 | Takeda Pharmaceuticals U.S.A., Inc. | $642 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-12-04 | Takeda Pharmaceuticals U.S.A., Inc. | $586 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-12-04 | Takeda Pharmaceuticals U.S.A., Inc. | $218 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-12-04 | Takeda Pharmaceuticals U.S.A., Inc. | $124 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-12-02 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2025 | |
| 2025-12-01 | Phathom Pharmaceuticals, Inc. | $7 | Food and Beverage | Cash or cash equivalent | VOQUEZNA Drug, Gastroenterology | 2025 | |
| 2025-11-25 | Janssen Biotech, Inc. | $24 | Food and Beverage | In-kind items and services | TREMFYA Drug, Immunology | 2025 | |
| 2025-11-24 | Madrigal Pharmaceuticals | $8 | Food and Beverage | In-kind items and services | REZDIFFRA Drug, LIVER DISEASE | 2025 | |
| 2025-11-20 | Janssen Biotech, Inc. | $4 | Food and Beverage | In-kind items and services | TREMFYA Drug, Immunology | 2025 | |
| 2025-11-17 | QOL Medical, LLC | $22 | Food and Beverage | In-kind items and services | Sucraid Drug, Genetic Disease | 2025 | |
| 2025-11-13 | Novo Nordisk Inc | $116 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-11-12 | Mirum Pharmaceuticals, Inc. | $21 | Food and Beverage | In-kind items and services | Livmarli Drug, Alagille syndrome | 2025 | |
| 2025-11-09 | Novo Nordisk Inc | $32 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-11-08 | Madrigal Pharmaceuticals | $54 | Food and Beverage | In-kind items and services | REZDIFFRA Drug, LIVER DISEASE | 2025 | |
| 2025-11-08 | Madrigal Pharmaceuticals | $50 | Food and Beverage | In-kind items and services | REZDIFFRA Drug, LIVER DISEASE | 2025 | |
| 2025-11-06 | Phathom Pharmaceuticals, Inc. | $8 | Food and Beverage | Cash or cash equivalent | VOQUEZNA Drug, Gastroenterology | 2025 | |
| 2025-11-05 | ABBVIE INC. | $5 | Food and Beverage | In-kind items and services | SKYRIZI Biological, IMMUNOLOGY | 2025 | |
| 2025-11-04 | Madrigal Pharmaceuticals | $16 | Food and Beverage | In-kind items and services | REZDIFFRA Drug, LIVER DISEASE | 2025 | |
| 2025-10-30 | Phathom Pharmaceuticals, Inc. | $8 | Food and Beverage | Cash or cash equivalent | VOQUEZNA Drug, Gastroenterology | 2025 | |
| 2025-10-25 | GENZYME CORPORATION | $29 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2025 | |
| 2025-10-20 | QOL Medical, LLC | $26 | Food and Beverage | In-kind items and services | Sucraid Drug, Genetic Disease | 2025 | |
| 2025-10-16 | GENZYME CORPORATION | $1,446 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-10-16 | Phathom Pharmaceuticals, Inc. | $9 | Food and Beverage | Cash or cash equivalent | VOQUEZNA Drug, Gastroenterology | 2025 | |
| 2025-10-13 | ABBVIE INC. | $18 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2025 | |
| 2025-10-08 | Janssen Biotech, Inc. | $97 | Food and Beverage | In-kind items and services | TREMFYA Drug, Immunology | 2025 | |
| 2025-10-02 | Madrigal Pharmaceuticals | $3,548 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REZDIFFRA Drug, LIVER DISEASE | 2025 | |
| 2025-10-02 | Madrigal Pharmaceuticals | $28 | Travel and Lodging | Cash or cash equivalent | REZDIFFRA Drug, LIVER DISEASE | 2025 | |
| 2025-10-02 | Madrigal Pharmaceuticals | $14 | Food and Beverage | In-kind items and services | REZDIFFRA Drug, LIVER DISEASE | 2025 | |
| 2025-10-02 | Madrigal Pharmaceuticals | $6 | Food and Beverage | In-kind items and services | REZDIFFRA Drug, LIVER DISEASE | 2025 | |
| 2025-10-02 | Madrigal Pharmaceuticals | $3 | Food and Beverage | In-kind items and services | REZDIFFRA Drug, LIVER DISEASE | 2025 | |
| 2025-09-30 | Janssen Biotech, Inc. | $143 | Food and Beverage | In-kind items and services | TREMFYA Drug, Immunology | 2025 | |
| 2025-09-25 | Janssen Biotech, Inc. | $21 | Food and Beverage | In-kind items and services | TREMFYA Drug, Immunology | 2025 | |
| 2025-09-22 | GENZYME CORPORATION | $17 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2025 | |
| 2025-09-18 | QOL Medical, LLC | $26 | Food and Beverage | In-kind items and services | Sucraid Drug, Genetic Disease | 2025 | |
| 2025-09-15 | Madrigal Pharmaceuticals | $16 | Food and Beverage | In-kind items and services | REZDIFFRA Drug, LIVER DISEASE | 2025 | |
| 2025-09-11 | Lilly USA, LLC | $46 | Food and Beverage | Cash or cash equivalent | 2025 | ||
| 2025-09-10 | ABBVIE INC. | $116 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2025 | |
| 2025-09-04 | ABBVIE INC. | $26 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2025 | |
| 2025-09-03 | GENZYME CORPORATION | $6 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2025 | |
| 2025-08-26 | ABBVIE INC. | $4 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2025 | |
| 2025-08-25 | GENZYME CORPORATION | $26 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2025 | |
| 2025-08-25 | Madrigal Pharmaceuticals | $7 | Food and Beverage | In-kind items and services | REZDIFFRA Drug, LIVER DISEASE | 2025 | |
| 2025-08-21 | Lilly USA, LLC | $14 | Food and Beverage | In-kind items and services | OMVOH Drug, Immunology | 2025 | |
| 2025-08-21 | Phathom Pharmaceuticals, Inc. | $6 | Food and Beverage | Cash or cash equivalent | VOQUEZNA Drug, Gastroenterology | 2025 | |
| 2025-08-18 | ABBVIE INC. | $15 | Food and Beverage | In-kind items and services | CREON Drug, ENDOCRINOLOGY | 2025 | |
| 2025-08-11 | Aimmune Therapeutics, Inc. | $22 | Food and Beverage | In-kind items and services | ZENPEP Drug, ENDOCRINE PANCREATIC INSUFFICIENCY | 2025 | |
| 2025-08-07 | Gilead Sciences, Inc. | $19 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-08-05 | ABBVIE INC. | $6 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2025 | |
| 2025-07-31 | Janssen Biotech, Inc. | $13 | Food and Beverage | In-kind items and services | TREMFYA Drug, Immunology | 2025 | |
| 2025-07-29 | AstraZeneca Pharmaceuticals LP | $68 | Education | In-kind items and services | IMFINZI Biological, Oncology | 2025 | |
| 2025-07-24 | ABBVIE INC. | $10 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2025 | |
| 2025-07-21 | Madrigal Pharmaceuticals | $20 | Food and Beverage | In-kind items and services | REZDIFFRA Drug, LIVER DISEASE | 2025 | |
| 2025-07-19 | Madrigal Pharmaceuticals | $94 | Food and Beverage | In-kind items and services | REZDIFFRA Drug, LIVER DISEASE | 2025 | |
| 2025-07-19 | Madrigal Pharmaceuticals | $70 | Food and Beverage | In-kind items and services | REZDIFFRA Drug, LIVER DISEASE | 2025 | |
| 2025-07-19 | Madrigal Pharmaceuticals | $57 | Food and Beverage | In-kind items and services | REZDIFFRA Drug, LIVER DISEASE | 2025 | |
| 2025-07-19 | Madrigal Pharmaceuticals | $38 | Food and Beverage | In-kind items and services | REZDIFFRA Drug, LIVER DISEASE | 2025 | |
| 2025-07-18 | Madrigal Pharmaceuticals | $6,127 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REZDIFFRA Drug, LIVER DISEASE | 2025 | |
| 2025-07-18 | Madrigal Pharmaceuticals | $551 | Travel and Lodging | In-kind items and services | REZDIFFRA Drug, LIVER DISEASE | 2025 | |
| 2025-07-18 | Madrigal Pharmaceuticals | $244 | Travel and Lodging | In-kind items and services | REZDIFFRA Drug, LIVER DISEASE | 2025 | |
| 2025-07-18 | Madrigal Pharmaceuticals | $231 | Travel and Lodging | In-kind items and services | REZDIFFRA Drug, LIVER DISEASE | 2025 | |
| 2025-07-18 | Madrigal Pharmaceuticals | $196 | Food and Beverage | In-kind items and services | REZDIFFRA Drug, LIVER DISEASE | 2025 | |
| 2025-07-18 | Madrigal Pharmaceuticals | $30 | Travel and Lodging | Cash or cash equivalent | REZDIFFRA Drug, LIVER DISEASE | 2025 | |
| 2025-07-18 | Madrigal Pharmaceuticals | $26 | Travel and Lodging | Cash or cash equivalent | REZDIFFRA Drug, LIVER DISEASE | 2025 | |
| 2025-07-17 | QOL Medical, LLC | $31 | Food and Beverage | In-kind items and services | Sucraid Drug, Genetic Disease | 2025 | |
| 2025-07-17 | Phathom Pharmaceuticals, Inc. | $4 | Food and Beverage | Cash or cash equivalent | VOQUEZNA Drug, Gastroenterology | 2025 | |
| 2025-07-10 | GENZYME CORPORATION | $15 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2025 | |
| 2025-07-07 | Madrigal Pharmaceuticals | $9 | Food and Beverage | In-kind items and services | REZDIFFRA Drug, LIVER DISEASE | 2025 | |
| 2025-07-02 | ABBVIE INC. | $6 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2025 | |
| 2025-06-30 | Madrigal Pharmaceuticals | $5 | Food and Beverage | In-kind items and services | REZDIFFRA Drug, LIVER DISEASE | 2025 | |
| 2025-06-26 | Janssen Biotech, Inc. | $84 | Education | In-kind items and services | TREMFYA Drug, Immunology | 2025 | |
| 2025-06-09 | Ardelyx, Inc. | $19 | Food and Beverage | In-kind items and services | IBSRELA Drug, GASTROENTEROLOGY | 2025 | |
| 2025-06-05 | GENZYME CORPORATION | $24 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2025 | |
| 2025-06-05 | Phathom Pharmaceuticals, Inc. | $6 | Food and Beverage | Cash or cash equivalent | VOQUEZNA Drug, Gastroenterology | 2025 | |
| 2025-06-04 | Madrigal Pharmaceuticals | $6 | Food and Beverage | In-kind items and services | REZDIFFRA Drug, LIVER DISEASE | 2025 | |
| 2025-06-03 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2025 | |
| 2025-06-02 | ABBVIE INC. | $18 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2025 | |
| 2025-05-29 | Lilly USA, LLC | $98 | Food and Beverage | Cash or cash equivalent | OMVOH Drug, Immunology | 2025 | |
| 2025-05-29 | Phathom Pharmaceuticals, Inc. | $4 | Food and Beverage | Cash or cash equivalent | VOQUEZNA Drug, Gastroenterology | 2025 | |
| 2025-05-28 | Janssen Biotech, Inc. | $94 | Food and Beverage | In-kind items and services | TREMFYA Drug, Immunology | 2025 | |
| 2025-05-22 | QOL Medical, LLC | $32 | Food and Beverage | In-kind items and services | Sucraid Drug, Genetic Disease | 2025 | |
| 2025-05-22 | Phathom Pharmaceuticals, Inc. | $5 | Food and Beverage | Cash or cash equivalent | VOQUEZNA Drug, Gastroenterology | 2025 | |
| 2025-05-19 | Janssen Biotech, Inc. | $15 | Food and Beverage | In-kind items and services | TREMFYA Drug, Immunology | 2025 | |
| 2025-05-15 | Janssen Biotech, Inc. | $11 | Food and Beverage | In-kind items and services | TREMFYA Drug, Immunology | 2025 | |
| 2025-04-28 | QOL Medical, LLC | $21 | Food and Beverage | In-kind items and services | Sucraid Drug, Genetic Disease | 2025 | |
| 2025-04-23 | Phathom Pharmaceuticals, Inc. | $19 | Travel and Lodging | Cash or cash equivalent | VOQUEZNA Drug, Gastroenterology | 2025 | |
| 2025-04-23 | Phathom Pharmaceuticals, Inc. | $15 | Travel and Lodging | Cash or cash equivalent | VOQUEZNA Drug, Gastroenterology | 2025 | |
| 2025-04-02 | Phathom Pharmaceuticals, Inc. | $2,400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VOQUEZNA Drug, Gastroenterology | 2025 | |
| 2025-03-25 | ABBVIE INC. | $5 | Food and Beverage | In-kind items and services | LINZESS Drug, GASTROENTEROLOGY | 2025 | |
| 2025-03-24 | Janssen Biotech, Inc. | $19 | Food and Beverage | In-kind items and services | TREMFYA Drug, Immunology | 2025 | |
| 2025-03-24 | Phathom Pharmaceuticals, Inc. | $18 | Food and Beverage | Cash or cash equivalent | VOQUEZNA Drug, Gastroenterology | 2025 | |
| 2025-03-20 | ABBVIE INC. | $26 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2025 | |
| 2025-03-19 | Phathom Pharmaceuticals, Inc. | $2,400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VOQUEZNA Drug, Gastroenterology | 2025 | |
| 2025-03-17 | Regeneron Healthcare Solutions, Inc. | $38 | Food and Beverage | In-kind items and services | DUPIXENT Biological, IMMUNOLOGY AND INFLAMMATION | 2025 | |
| 2025-03-13 | Madrigal Pharmaceuticals | $102 | Food and Beverage | In-kind items and services | REZDIFFRA Drug, LIVER DISEASE | 2025 | |
| 2025-03-13 | Phathom Pharmaceuticals, Inc. | $28 | Food and Beverage | Cash or cash equivalent | VOQUEZNA Drug, Gastroenterology | 2025 | |
| 2025-03-13 | Lilly USA, LLC | $21 | Food and Beverage | In-kind items and services | OMVOH Drug, Immunology | 2025 | |
| 2025-03-11 | Phathom Pharmaceuticals, Inc. | $57 | Food and Beverage | Cash or cash equivalent | VOQUEZNA Drug, Gastroenterology | 2025 | |
| 2025-03-10 | Madrigal Pharmaceuticals | $18 | Food and Beverage | In-kind items and services | REZDIFFRA Drug, LIVER DISEASE | 2025 | |
| 2025-03-06 | ABBVIE INC. | $113 | Food and Beverage | In-kind items and services | SKYRIZI Biological, IMMUNOLOGY | 2025 | |
| 2025-03-06 | ABBVIE INC. | $23 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2025 | |
| 2025-03-06 | Phathom Pharmaceuticals, Inc. | $6 | Food and Beverage | Cash or cash equivalent | VOQUEZNA Drug, Gastroenterology | 2025 | |
| 2025-03-05 | Inspire Medical Systems, Inc. | $117 | Food and Beverage | In-kind items and services | INSPIRE Device, NEUROLOGY | 2025 | |
| 2025-03-03 | Janssen Biotech, Inc. | $19 | Food and Beverage | In-kind items and services | TREMFYA Drug, Immunology | 2025 | |
| 2025-02-24 | Janssen Biotech, Inc. | $24 | Food and Beverage | In-kind items and services | TREMFYA Drug, Immunology | 2025 | |
| 2025-02-24 | Janssen Biotech, Inc. | $12 | Food and Beverage | In-kind items and services | TREMFYA Drug, Immunology | 2025 | |
| 2025-02-20 | QOL Medical, LLC | $37 | Food and Beverage | In-kind items and services | Sucraid Drug, Genetic Disease | 2025 | |
| 2025-02-19 | Phathom Pharmaceuticals, Inc. | $38 | Travel and Lodging | Cash or cash equivalent | VOQUEZNA Drug, Gastroenterology | 2025 | |
| 2025-02-06 | Madrigal Pharmaceuticals | $130 | Food and Beverage | In-kind items and services | REZDIFFRA Drug, LIVER DISEASE | 2025 | |
| 2025-02-06 | Regeneron Healthcare Solutions, Inc. | $35 | Food and Beverage | In-kind items and services | DUPIXENT Biological, IMMUNOLOGY AND INFLAMMATION | 2025 | |
| 2025-02-04 | ABBVIE INC. | $10 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2025 | |
| 2025-01-29 | Phathom Pharmaceuticals, Inc. | $20 | Travel and Lodging | Cash or cash equivalent | VOQUEZNA Drug, Gastroenterology | 2025 | |
| 2025-01-29 | Janssen Biotech, Inc. | $8 | Food and Beverage | In-kind items and services | TREMFYA Drug, Immunology | 2025 | |
| 2025-01-23 | Phathom Pharmaceuticals, Inc. | $3,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VOQUEZNA Drug, Gastroenterology | 2025 | |
| 2025-01-23 | Madrigal Pharmaceuticals | $22 | Food and Beverage | In-kind items and services | REZDIFFRA Drug, LIVER DISEASE | 2025 | |
| 2025-01-23 | Phathom Pharmaceuticals, Inc. | $6 | Food and Beverage | Cash or cash equivalent | VOQUEZNA Drug, Gastroenterology | 2025 | |
| 2025-01-21 | Janssen Biotech, Inc. | $2 | Food and Beverage | In-kind items and services | TREMFYA Drug, Immunology | 2025 | |
| 2025-01-16 | Lilly USA, LLC | $22 | Food and Beverage | In-kind items and services | OMVOH Drug, Immunology | 2025 | |
| 2025-01-15 | Phathom Pharmaceuticals, Inc. | $1,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VOQUEZNA Drug, Gastroenterology | 2025 | |
| 2025-01-13 | Phathom Pharmaceuticals, Inc. | $26 | Food and Beverage | Cash or cash equivalent | VOQUEZNA Drug, Gastroenterology | 2025 | |
| 2025-01-03 | Phathom Pharmaceuticals, Inc. | $2,400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VOQUEZNA Drug, Gastroenterology | 2025 | |
| 2024-12-19 | Phathom Pharmaceuticals, Inc. | $17 | Food and Beverage | In-kind items and services | VOQUEZNA Drug, GASTROENTEROLOGY | 2024 | |
| 2024-12-19 | Phathom Pharmaceuticals, Inc. | $5 | Food and Beverage | In-kind items and services | VOQUEZNA Drug, GASTROENTEROLOGY | 2024 | |
| 2024-12-16 | Merck Sharp & Dohme LLC | $18 | Food and Beverage | In-kind items and services | DIFICID Drug, INFECTIOUS DISEASE | 2024 | |
| 2024-12-09 | Lilly USA, LLC | $20 | Food and Beverage | In-kind items and services | OMVOH Drug, Immunology | 2024 | |
| 2024-12-05 | ABBVIE INC. | $11 | Food and Beverage | In-kind items and services | SKYRIZI Biological, IMMUNOLOGY | 2024 | |
| 2024-12-02 | Janssen Biotech, Inc. | $50 | Food and Beverage | In-kind items and services | TREMFYA Drug, Immunology | 2024 | |
| 2024-12-02 | ABBVIE INC. | $6 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2024 | |
| 2024-12-02 | Phathom Pharmaceuticals, Inc. | $5 | Food and Beverage | In-kind items and services | VOQUEZNA Drug, GASTROENTEROLOGY | 2024 | |
| 2024-11-25 | Takeda Pharmaceuticals U.S.A., Inc. | $30 | Food and Beverage | In-kind items and services | ENTYVIO Biological, INTERNAL MEDICINE | 2024 | |
| 2024-11-19 | Janssen Biotech, Inc. | $139 | Food and Beverage | In-kind items and services | TREMFYA Drug, Immunology | 2024 | |
| 2024-11-19 | Janssen Biotech, Inc. | $10 | Food and Beverage | In-kind items and services | TREMFYA Drug, Immunology | 2024 | |
| 2024-11-13 | Phathom Pharmaceuticals, Inc. | $40 | Travel and Lodging | Cash or cash equivalent | VOQUEZNA Drug, GASTROENTEROLOGY | 2024 | |
| 2024-11-13 | Phathom Pharmaceuticals, Inc. | $18 | Travel and Lodging | Cash or cash equivalent | VOQUEZNA Drug, GASTROENTEROLOGY | 2024 | |
| 2024-10-24 | Janssen Biotech, Inc. | $24 | Food and Beverage | In-kind items and services | TREMFYA Drug, Immunology | 2024 | |
| 2024-10-14 | ABBVIE INC. | $20 | Food and Beverage | In-kind items and services | CREON Drug, ENDOCRINOLOGY | 2024 | |
| 2024-10-14 | Phathom Pharmaceuticals, Inc. | $2 | Food and Beverage | In-kind items and services | VOQUEZNA Drug, GASTROENTEROLOGY | 2024 | |
| 2024-10-10 | Lilly USA, LLC | $22 | Food and Beverage | In-kind items and services | OMVOH Drug, Immunology | 2024 | |
| 2024-10-09 | Phathom Pharmaceuticals, Inc. | $3,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VOQUEZNA Drug, GASTROENTEROLOGY | 2024 | |
| 2024-10-09 | Phathom Pharmaceuticals, Inc. | $2,400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VOQUEZNA Drug, GASTROENTEROLOGY | 2024 | |
| 2024-10-07 | ABBVIE INC. | $19 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2024 | |
| 2024-10-04 | Phathom Pharmaceuticals, Inc. | $29 | Food and Beverage | In-kind items and services | VOQUEZNA Drug, GASTROENTEROLOGY | 2024 | |
| 2024-10-03 | Takeda Pharmaceuticals U.S.A., Inc. | $19 | Food and Beverage | In-kind items and services | ENTYVIO Biological, INTERNAL MEDICINE | 2024 | |
| 2024-10-02 | Phathom Pharmaceuticals, Inc. | $123 | Food and Beverage | In-kind items and services | VOQUEZNA Drug, GASTROENTEROLOGY | 2024 | |
| 2024-09-27 | Janssen Biotech, Inc. | $27 | Food and Beverage | In-kind items and services | TREMFYA Drug, Immunology | 2024 | |
| 2024-09-27 | Janssen Biotech, Inc. | $3 | Food and Beverage | In-kind items and services | TREMFYA Drug, Immunology | 2024 | |
| 2024-09-19 | Phathom Pharmaceuticals, Inc. | $5 | Food and Beverage | In-kind items and services | VOQUEZNA Drug, GASTROENTEROLOGY | 2024 | |
| 2024-09-12 | ABBVIE INC. | $22 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2024 | |
| 2024-09-09 | Gilead Sciences, Inc. | $16 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-09-05 | Phathom Pharmaceuticals, Inc. | $3 | Food and Beverage | In-kind items and services | VOQUEZNA Drug, GASTROENTEROLOGY | 2024 | |
| 2024-08-28 | Phathom Pharmaceuticals, Inc. | $56 | Travel and Lodging | Cash or cash equivalent | VOQUEZNA Drug, GASTROENTEROLOGY | 2024 | |
| 2024-08-28 | Phathom Pharmaceuticals, Inc. | $10 | Food and Beverage | Cash or cash equivalent | VOQUEZNA Drug, GASTROENTEROLOGY | 2024 | |
| 2024-08-12 | Phathom Pharmaceuticals, Inc. | $2 | Food and Beverage | In-kind items and services | VOQUEZNA Drug, GASTROENTEROLOGY | 2024 | |
| 2024-08-01 | Phathom Pharmaceuticals, Inc. | $9 | Food and Beverage | In-kind items and services | VOQUEZNA Drug, GASTROENTEROLOGY | 2024 | |
| 2024-07-31 | Phathom Pharmaceuticals, Inc. | $46 | Travel and Lodging | Cash or cash equivalent | VOQUEZNA Drug, GASTROENTEROLOGY | 2024 | |
| 2024-07-31 | Phathom Pharmaceuticals, Inc. | $37 | Travel and Lodging | Cash or cash equivalent | VOQUEZNA Drug, GASTROENTEROLOGY | 2024 | |
| 2024-07-29 | ABBVIE INC. | $24 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2024 | |
| 2024-07-27 | Phathom Pharmaceuticals, Inc. | $55 | Food and Beverage | In-kind items and services | VOQUEZNA Drug, GASTROENTEROLOGY | 2024 | |
| 2024-07-27 | Phathom Pharmaceuticals, Inc. | $47 | Food and Beverage | In-kind items and services | VOQUEZNA Drug, GASTROENTEROLOGY | 2024 | |
| 2024-07-27 | Phathom Pharmaceuticals, Inc. | $35 | Food and Beverage | In-kind items and services | VOQUEZNA Drug, GASTROENTEROLOGY | 2024 | |
| 2024-07-27 | Phathom Pharmaceuticals, Inc. | $29 | Food and Beverage | In-kind items and services | VOQUEZNA Drug, GASTROENTEROLOGY | 2024 | |
| 2024-07-27 | Phathom Pharmaceuticals, Inc. | $29 | Food and Beverage | In-kind items and services | VOQUEZNA Drug, GASTROENTEROLOGY | 2024 | |
| 2024-07-26 | Phathom Pharmaceuticals, Inc. | $496 | Travel and Lodging | In-kind items and services | VOQUEZNA Drug, GASTROENTEROLOGY | 2024 | |
| 2024-07-26 | Phathom Pharmaceuticals, Inc. | $346 | Travel and Lodging | In-kind items and services | VOQUEZNA Drug, GASTROENTEROLOGY | 2024 | |
| 2024-07-26 | Phathom Pharmaceuticals, Inc. | $135 | Food and Beverage | In-kind items and services | VOQUEZNA Drug, GASTROENTEROLOGY | 2024 | |
| 2024-07-24 | Phathom Pharmaceuticals, Inc. | $4,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VOQUEZNA Drug, GASTROENTEROLOGY | 2024 | |
| 2024-07-23 | Janssen Biotech, Inc. | $8 | Food and Beverage | In-kind items and services | STELARA Biological, Immunology | 2024 | |
| 2024-07-22 | ABBVIE INC. | $21 | Food and Beverage | In-kind items and services | CREON Drug, ENDOCRINOLOGY | 2024 | |
| 2024-07-18 | Phathom Pharmaceuticals, Inc. | $7 | Food and Beverage | In-kind items and services | VOQUEZNA Drug, GASTROENTEROLOGY | 2024 | |
| 2024-07-12 | ABBVIE INC. | $29 | Food and Beverage | In-kind items and services | SKYRIZI Biological, IMMUNOLOGY | 2024 | |
| 2024-07-11 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $20 | Food and Beverage | In-kind items and services | TRULANCE Drug, Gastroenterology | 2024 | |
| 2024-07-10 | ABBVIE INC. | $116 | Food and Beverage | In-kind items and services | SKYRIZI Biological, IMMUNOLOGY | 2024 | |
| 2024-07-09 | Lilly USA, LLC | $19 | Food and Beverage | In-kind items and services | OMVOH Drug, Immunology | 2024 | |
| 2024-07-03 | Phathom Pharmaceuticals, Inc. | $2,400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VOQUEZNA Drug, GASTROENTEROLOGY | 2024 | |
| 2024-06-28 | Phathom Pharmaceuticals, Inc. | $20 | Food and Beverage | In-kind items and services | VOQUEZNA Drug, GASTROENTEROLOGY | 2024 | |
| 2024-06-27 | ABBVIE INC. | $25 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2024 | |
| 2024-06-20 | Regeneron Healthcare Solutions, Inc. | $14 | Food and Beverage | In-kind items and services | DUPIXENT Biological, INFLAMMATION AND IMMUNOLOGY | 2024 | |
| 2024-06-19 | Phathom Pharmaceuticals, Inc. | $3,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VOQUEZNA Drug, GASTROENTEROLOGY | 2024 | |
| 2024-06-14 | Phathom Pharmaceuticals, Inc. | $30 | Food and Beverage | In-kind items and services | VOQUEZNA Drug, GASTROENTEROLOGY | 2024 | |
| 2024-06-13 | Merck Sharp & Dohme LLC | $17 | Food and Beverage | In-kind items and services | DIFICID Drug, INFECTIOUS DISEASE | 2024 | |
| 2024-06-05 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | LINZESS Drug, GASTROENTEROLOGY | 2024 | |
| 2024-06-03 | Lilly USA, LLC | $19 | Food and Beverage | In-kind items and services | OMVOH Drug, Immunology | 2024 | |
| 2024-05-24 | Janssen Biotech, Inc. | $90 | Food and Beverage | In-kind items and services | STELARA Biological, Immunology | 2024 | |
| 2024-05-23 | Janssen Biotech, Inc. | $2 | Food and Beverage | In-kind items and services | STELARA Biological, Immunology | 2024 | |
| 2024-05-20 | ABBVIE INC. | $22 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2024 | |
| 2024-05-20 | Phathom Pharmaceuticals, Inc. | $6 | Food and Beverage | In-kind items and services | VOQUEZNA Drug, GASTROENTEROLOGY | 2024 | |
| 2024-05-16 | QOL Medical, LLC | $37 | Food and Beverage | Cash or cash equivalent | SUCRAID Drug, THERAPY FOR CSID | 2024 | |
| 2024-05-15 | Phathom Pharmaceuticals, Inc. | $1,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VOQUEZNA Drug, GASTROENTEROLOGY | 2024 | |
| 2024-05-15 | Phathom Pharmaceuticals, Inc. | $900 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VOQUEZNA Drug, GASTROENTEROLOGY | 2024 | |
| 2024-05-13 | ABBVIE INC. | $21 | Food and Beverage | In-kind items and services | LINZESS Drug, GASTROENTEROLOGY | 2024 | |
| 2024-05-09 | Phathom Pharmaceuticals, Inc. | $7 | Food and Beverage | In-kind items and services | VOQUEZNA Drug, GASTROENTEROLOGY | 2024 | |
| 2024-05-08 | ABBVIE INC. | $115 | Food and Beverage | In-kind items and services | SKYRIZI Biological, IMMUNOLOGY | 2024 | |
| 2024-05-06 | Ferring Pharmaceuticals Inc. | $17 | Food and Beverage | In-kind items and services | REBYOTA Biological, GASTROENTEROLOGY | 2024 |
The latest 200 records of 365.
Research payments naming this person as principal investigator
| Date | Company | Paid to | Amount | Study | Year |
|---|---|---|---|---|---|
| 2021-02-02 | Takeda Pharmaceuticals U.S.A., Inc. | GASTROENTEROL ASSOC OF HAZARD | $1,000 | STUDY OF THE EFFECT OF SHP647 AS MAINTENANCE TREATMENT IN PARTICIPANTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS WHO AC | 2021 |
| 2021-01-26 | Takeda Pharmaceuticals U.S.A., Inc. | GASTROENTEROL ASSOC OF HAZARD | $1,000 | A PHASE 3 LONG-TERM SAFETY EXTENSION STUDY OF SHP647 IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS (AIDA) | 2021 |
| 2020-03-05 | Adare Pharmaceuticals, Inc. | GASTROENTEROLOGY ASSOCIATES OF HAZARD | $1,036 | Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE) (FLUTE) | 2020 |
| 2020-03-05 | Adare Pharmaceuticals, Inc. | GASTROENTEROLOGY ASSOCIATES OF HAZARD | $956 | Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE) (FLUTE) | 2020 |
| 2020-03-05 | Adare Pharmaceuticals, Inc. | GASTROENTEROLOGY ASSOCIATES OF HAZARD | $462 | Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE) (FLUTE) | 2020 |
| 2020-03-02 | Adare Pharmaceuticals, Inc. | GASTROENTEROLOGY ASSOCIATES OF HAZARD | $3,833 | Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE) (FLUTE) | 2020 |
| 2020-01-14 | Adare Pharmaceuticals, Inc. | GASTROENTEROLOGY ASSOCIATES OF HAZARD | $152 | Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE) (FLUTE) | 2020 |
| 2020-01-14 | Adare Pharmaceuticals, Inc. | GASTROENTEROLOGY ASSOCIATES OF HAZARD | $2,400 | Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE) (FLUTE) | 2020 |
| 2019-11-11 | Adare Pharmaceuticals, Inc. | GASTROENTEROLOGY ASSOCIATES OF HAZARD PSC | $806 | SP-1011-002 | 2019 |
| 2019-10-23 | Adare Pharmaceuticals, Inc. | GASTROENTEROLOGY ASSOCIATES OF HAZARD PSC | $895 | SP-1011-002 | 2019 |
| 2019-10-23 | Adare Pharmaceuticals, Inc. | GASTROENTEROLOGY ASSOCIATES OF HAZARD PSC | $2,422 | SP-1011-002 | 2019 |
| 2019-08-12 | Adare Pharmaceuticals, Inc. | GASTROENTEROLOGY ASSOCIATES OF HAZARD PSC | $805 | SP-1011-002 | 2019 |
| 2019-07-15 | Adare Pharmaceuticals, Inc. | GASTROENTEROLOGY ASSOCIATES OF HAZARD PSC | $535 | SP-1011-002 | 2019 |
| 2019-06-19 | Gilead Sciences, Inc. | GASTROENTEROLOGY ASSOCIATES OF HAZARD PSC | $163 | STELLAR-3 A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonserti | 2019 |
| 2019-06-14 | Adare Pharmaceuticals, Inc. | GASTROENTEROLOGY ASSOCIATES OF HAZARD PSC | $535 | SP-1011-002 | 2019 |
| 2019-05-22 | Gilead Sciences, Inc. | GASTROENTEROLOGY ASSOCIATES OF HAZARD PSC | $1,105 | STELLAR-3 A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonserti | 2019 |
| 2019-05-22 | Gilead Sciences, Inc. | GASTROENTEROLOGY ASSOCIATES OF HAZARD PSC | $163 | STELLAR-4 A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonserti | 2019 |
| 2019-05-13 | Adare Pharmaceuticals, Inc. | GASTROENTEROLOGY ASSOCIATES OF HAZARD PSC | $2,049 | SP-1011-002 | 2019 |
| 2019-05-13 | Adare Pharmaceuticals, Inc. | GASTROENTEROLOGY ASSOCIATES OF HAZARD PSC | $656 | SP-1011-002 | 2019 |
| 2019-05-13 | Adare Pharmaceuticals, Inc. | GASTROENTEROLOGY ASSOCIATES OF HAZARD PSC | $656 | SP-1011-002 | 2019 |
| 2019-05-13 | Adare Pharmaceuticals, Inc. | GASTROENTEROLOGY ASSOCIATES OF HAZARD PSC | $2,726 | SP-1011-002 | 2019 |
| 2019-04-17 | Gilead Sciences, Inc. | GASTROENTEROLOGY ASSOCIATES OF HAZARD PSC | $1,669 | STELLAR-4 A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonserti | 2019 |
| 2019-04-17 | Gilead Sciences, Inc. | GASTROENTEROLOGY ASSOCIATES OF HAZARD PSC | $1,063 | STELLAR-3 A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonserti | 2019 |
| 2019-03-18 | Adare Pharmaceuticals, Inc. | GASTROENTEROLOGY ASSOCIATES OF HAZARD PSC | $868 | SP-1011-002 | 2019 |
| 2019-03-18 | Adare Pharmaceuticals, Inc. | GASTROENTEROLOGY ASSOCIATES OF HAZARD PSC | $694 | SP-1011-002 | 2019 |
| 2019-02-20 | Gilead Sciences, Inc. | GASTROENTEROLOGY ASSOCIATES OF HAZARD PSC | $163 | STELLAR-3 A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonserti | 2019 |
| 2019-02-20 | Gilead Sciences, Inc. | GASTROENTEROLOGY ASSOCIATES OF HAZARD PSC | $1,063 | STELLAR-4 A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonserti | 2019 |
| 2019-02-19 | Adare Pharmaceuticals, Inc. | GASTROENTEROLOGY ASSOCIATES OF HAZARD PSC | $824 | SP-1011-002 | 2019 |
| 2019-02-19 | Adare Pharmaceuticals, Inc. | GASTROENTEROLOGY ASSOCIATES OF HAZARD PSC | $659 | SP-1011-002 | 2019 |
| 2019-02-19 | Adare Pharmaceuticals, Inc. | GASTROENTEROLOGY ASSOCIATES OF HAZARD PSC | $300 | SP-1011-002 | 2019 |
| 2019-01-28 | Gilead Sciences, Inc. | GASTROENTEROLOGY ASSOCIATES OF HAZARD PSC | $5,718 | STELLAR-3 A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonserti | 2019 |
| 2019-01-18 | Adare Pharmaceuticals, Inc. | GASTROENTEROLOGY ASSOCIATES OF HAZARD PSC | $1,005 | SP-1011-002 | 2019 |
| 2019-01-18 | Adare Pharmaceuticals, Inc. | GASTROENTEROLOGY ASSOCIATES OF HAZARD PSC | $2,863 | SP-1011-002 | 2019 |
| 2019-01-18 | Adare Pharmaceuticals, Inc. | GASTROENTEROLOGY ASSOCIATES OF HAZARD PSC | $2,089 | SP-1011-002 | 2019 |
| 2019-01-18 | Adare Pharmaceuticals, Inc. | GASTROENTEROLOGY ASSOCIATES OF HAZARD PSC | $1,005 | SP-1011-002 | 2019 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Hazard, KY, county Perry County, KY, state Kentucky; placed by its city name.
| Measure | Place (city or town) Hazard, KY | County Perry County, KY | State Kentucky |
|---|---|---|---|
| Population B01003 | 5,008 | 27,499 | 4,534,824 |
| Population, 2020 census P1 | 5,263 | 28,473 | 4,505,836 |
| Median age B01002 | 42.2 | 41.5 | 39.1 |
| Under 18 B01001 | 19.1% | 23.4% | 22.6% |
| 65 and over B01001 | 18.7% | 18.0% | 17.3% |
| Households B11001 | 2,024 | 11,078 | 1,814,469 |
| Foreign born B05002 | 0.2% | 0.9% | 4.7% |
| Median household income B19013 | $51,016 | $42,181 | $63,726 |
| Median family income B19113 | $50,313 | $54,269 | $81,505 |
| Per capita income B19301 | $52,395 | $28,931 | $35,821 |
| Poverty rate B17001 | 31.5% | 26.8% | 16.1% |
| Unemployment rate B23025 | 7.1% | 5.8% | 4.9% |
| Civilian labor force B23025 | 1,859 | 10,361 | 2,152,038 |
| Mean commute (minutes) B08013 | 13.8 | 24.8 | 24.0 |
| Bachelor's degree or higher B15003 | 23.6% | 14.8% | 27.6% |
| Housing units B25001 | 2,346 | 13,295 | 2,023,116 |
| Owner-occupied B25003 | 53.5% | 70.4% | 68.3% |
| Renters B25003 | 46.5% | 29.6% | 31.7% |
| Median home value B25077 | $145,400 | $91,800 | $205,600 |
| Median gross rent B25064 | $720 | $798 | $967 |
| White, not Hispanic B03002 | 88.4% | 93.7% | 81.5% |
| Black B03002 | 3.8% | 1.7% | 7.6% |
| Hispanic or Latino B03002 | 0.9% | 0.2% | 5.0% |
| Asian B03002 | 0.2% | 0.6% | 1.6% |
| American Indian and Alaska Native B03002 | 0.2% | 0.1% | 0.1% |
Economy now FRED unemployment 4.7% in Sep 2026 (4.5% a year earlier); per capita personal income $60,835 in 2025, up 29% in five years (+3.9% after inflation); the state; Source: FRED, Federal Reserve Bank of St. Louis.
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Hazard, KY.
Comments